Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)
All MBC
Triple-Negative
- Targeted Therapy GSK3326595 for Advanced HER2- Breast (and Other) Cancers
- Taxol Alone or With Ipatasertib and/or Atezolizumab in Advanced Triple Negative Breast Cancer
- BT5528 Alone or With Nivolumab in Advanced Triple Negative Breast Cancer That Tests EphA2+
- Targeted Therapy PMD-026 for Metastatic Triple Negative Breast Cancer
- mRNA-2752 & Durvalumab for Advanced Triple Negative Breast Cancer
- Entinostat & Capecitabine for Stage II, Stage III or Metastatic HER2 Negative Breast Cancer
HR Positive (HR+)
Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.
